To Evaluate the Role of HbA1C as a Predictor for the Development of Diabetic Nephropathy in Type 1 Diabetic Patients

Dr. Sushant Duddala; Arghadip Das; Shaibesh M Shrestha; Dr. Snigdha Shanti Cheela; Dr. Himani J Suthar; Dr. Vinodh Boopalraj

Authors

Dr. Sushant Duddala
Arghadip Das
Shaibesh M Shrestha
Dr. Snigdha Shanti Cheela
Dr. Himani J Suthar
Dr. Vinodh Boopalraj

Keywords:

type 1 diabetic, diabeti c nephropathy, glycosylated hemoglobin (HbA1C)

Abstract

Abstract not found

Downloads

Article PDF

How to Cite

To Evaluate the Role of HbA1C as a Predictor for the Development of Diabetic Nephropathy in Type 1 Diabetic Patients. (2022). Global Journal of Medical Research, 22(F4), 3-8. https://medicalresearchjournal.org/index.php/GJMR/article/view/101773

Download Citation

References

American Diabetic, Association (2015) Standards of medical care in diabetes-2015. 38(1), 8-93.

C Mogensen (1982) Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. 285(6343), 685-688.

Hans-Henrik Parving, Ulla Smidt, Allan Andersen, Peraa Svendsen (1983) EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHY. 321(8335), 1175-1179.

Edmund Lewis, Lawrence Hunsicker, Raymond Bain, Richard Rohde (1993) The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy. 329(20), 1456-1462.

The Dcct Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long term complications in insulindependent diabetes mellitus: The Diabetes Control And Complications Trial Research Group. 329, 977-986.

D Mccane, R Hanson, M Charles, Lth Jacobsson, D Pettitt, P Bennett, W Knowler (1994) Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. 308(6940), 1323-1328.

Diabetes Uk Prospective, ( Study, Ukpds) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). 352, 837-853.

R Tapp, P Zimmet, C Harper, M De Courten, D Mccarty, B Balkau, H Taylor, T Welborn, J Shaw (2006) Diagnostic thresholds for diabetes: The association of retinopathy and albuminuria with glycaemia. 73(3), 315-321.

American Diabetic, Association (2007) Standards of Medical Care in Diabetes-2007. 30(suppl_1), S4-S41.

C Ito, R Maeda, S Ishida, H Sasaki, H Harada (2000) Correlation among fasting plasma glucose, twohour plasma glucose levels in OGTT and HbA1c. 50, 225-230.

C Sabanayagam, G Liew, E Tai, A Shankar, S Lim, T Subramaniam, T Wong (2009) Relationship between glycated haemoglobin and microvascular complications: Is there a natural cut-off point for the diagnosis of diabetes?. 52(7), 1279-1289.

Domingo Hernandez, Ana Espejo-Gil, M Bernal-Lopez, Jose Mancera-Romero, Antonio Baca-Osorio, Francisco Tinahones, Ana Armas-Padron, Pedro Ruiz-Esteban, Armando Torres, Ricardo Gomez-Huelgas (2013) Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population. 14(1), 151.

A Patel, S Macmaho, J Chalmers, B Neal, L Billot, M Woodward (2008) Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. 358(24), 2560-2572.

Ksvhari Kumar, K Modi, A Basile, S Kota (2012) Profile of microvascular disease in type 2 diabetes in a tertiary health care hospital in India. 2(2), 103.

R Agrawal, A Kochar, K Kaswan, S Sharma, D Kochar (2004) Need a Better Recognition - MMDM. 25(2), 55.

F Giorgino, L Laviola, P Cavallo Perin, B Solnica, J Fuller, N Chaturvedi (2004) Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study. 47(6), 1020-1028.

Stephen Fava, Joseph Azzopardi, Andrew Hattersley, Peter Watkins (2000) Increased prevalence of proteinuria in diabetic sibs of proteinuric type 2 diabetic subjects. 35(4), 708-712.

Robert Nelson, William Knowler, David Pettitt, Mohammed Saad, Peter Bennett (1993) Diabetic Kidney Disease in Pima Indians. 16(1), 335-341.

Amanda Adler, Richard Stevens, Sue Manley, Rudy Bilous, Carole Cull, Rury Holman, Ukpds Group (2003) Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). 63(1), 225-232.

(2003) Diabetic Nephropathy. 26(suppl_1), s94-s98.

(1987) Consensus Statement on Self-Monitor ing of Blood Glucose. 10(1), 95-99.

S Mauer, M Steffes, E Ellis, D Sutherland, D Brwn, F Goetz (1984) Structural-functional relationships in diabetic nephropathy. 74, 1143-1155.

D Hernandez, A Espejo-Gil, M Bernal-Lopez, J Mancera-Romero, A Baca-Osorio, F Tinahones (2013) Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population. 14, 151.

S Zoungas, J Chalmers, T Ninomiya, Q Li, M Cooper, S Colagiuri, G Fulcher, B De Galan, S Harrap, P Hamet, S Heller, S Macmahon, M Marre, N Poulter, F Travert, A Patel, B Neal, M Woodward (2012) Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. 55(3), 636-643.

Keith Drummond, Michael Kramer, Samy Suissa, Claire Lévy-Marchal, Sophie Dell'aniello, Alan Sinaiko, Michael Mauer (2003) Effects of Duration and Age at Onset of Type 1 Diabetes on Preclinical Manifestations of Nephropathy. 52(7), 1818-1824.

K Donaghue, J Fairchild, M Craig, A Chan, S Fracnzo, L Cutler (2003) Do all prepubertal years of diabetes duration contribute equally to diabetes complications?. 26, 1224-1229.

R Holl, M Grabert, A Thon, E Heinze (1999) Urinary excretion of albumin in adolescents with type 1 diabetes. 22(9), 1555-1560.

Liying Zhang, Georges Krzentowski, Adelin Albert, Pierre Lefebvre (2001) Risk of Developing Retinopathy in Diabetes Control and Complications Trial Type 1 Diabetic Patients With Good or Poor Metabolic Control. 24(7), 1275-1279.

Dcct The (1993) The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. 329(14), 977-986.

Joyce D'antonio, Demetrius Ellis, Bernard Doft, Dorothy Becker, Allan Drash, Lewis Kuller, Trevor Orchard (1989) Diabetes Complications and Glycemk Control: The Pittsburgh Prospective Insulin-Dependent Diabetes Cohort Study Status Report After 5 yr of IDDM. 12(10), 694-700.

Mark Cooper (1998) Pathogenesis, prevention, and treatment of diabetic nephropathy. 352(9123), 213-219.

Justin Maxhimer, Michael Somenek, Geetha Rao, Catherine Pesce, David Baldwin, Paolo Gattuso, Melvin Schwartz, Edmund Lewis, Richard Prinz, Xiulong Xu (2005) Heparanase-1 Gene Expression and Regulation by High Glucose in Renal Epithelial Cells. 54(7), 2172-2178.

T Hayashida, H Schnaper (2004) High ambient glucose enhances sensitivity to TGF-beta1 via extracellular signal-regulated kinase and protein kinase Cdelta activities in human mesangial cells. 15(8), 2032-2041.

B Hohenstein, B Hausknecht, K Boehmer, R Riess, R Brekken, C Hugo (2006) Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. 69(9), 1654-1661.

Joshua Barzilay, James Warram, Marianna Bak, Lori Laffel, Mitzy Canessa, Andrzej Krolewski (1992) Predisposition to hypertension: Risk factor for nephropathy and hypertension in IDDM. 41(4), 723-730.

S De Cosmo, S Bacci, G Piras, M Cignarelli, G Placentino, M Margaglione, D Colaizzo, G Di Minno, R Giorgino, A Liuzzi, G Viberti (1997) High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria. 40(10), 1191-1196.